Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-005790

Options or other derivatives

  • Chief Financial Officer acquired 61,822 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Musso Alan A Chief Financial Officer 2024-01-17 Grant or award · Stock Option (right to buy) +61,822 61,822 D: show line 1 in the form
Loading xslF345X05/ownership.xml…